# Blood-Filtering Therapy Shows Promise for Preeclampsia
Researchers tested a blood-filtering treatment on pregnant women with preeclampsia, a dangerous condition that raises blood pressure and can harm both mother and fetus. The pilot study found the therapy safe for patients and their developing babies.
Preeclampsia affects roughly 3-5% of pregnancies and remains a leading cause of maternal death worldwide. Current treatments focus on managing symptoms or delivering the baby early, which carries risks for premature infants.
The blood-filtering approach works by removing harmful substances from the mother's blood. These toxins accumulate in preeclampsia and trigger the condition's severe effects. By filtering them out, researchers hope to reduce dangerous blood pressure spikes and organ damage.
The pilot study enrolled a small group of pregnant women. Doctors monitored both mothers and fetuses closely throughout treatment. Results showed no serious adverse effects in either group, suggesting the therapy does not harm fetal development.
Researchers plan larger trials to confirm whether blood filtering actually improves outcomes and reduces the need for early delivery. If successful, this treatment could offer pregnant women a new option beyond current symptom management. The work represents a shift from treating preeclampsia's effects to addressing its underlying cause.